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Human T-cell leukaemia virus type I (HTLV-I) Tax regulates viral and cellular gene expression
through interactions with multiple cellular transcription pathways. This study describes the finding
of immediate–early gene ETR101 expression in HTLV-I-infected cells and its regulation by Tax.
ETR101 was persistently expressed in HTLV-I-infected cells but not in HTLV-I uninfected cells.
Expression of ETR101 was dependent upon Tax expression in the inducible Tax-expressing
cell line JPX-9 and also in Jurkat cells transiently transfected with Tax-expressing vectors. Tax
transactivated the ETR101 gene promoter in a transient transfection assay. A series of deletion and
mutation analyses of the ETR101 gene promoter indicated that a 35 bp region immediately
upstream of the TATA-box sequence, which contains a consensus cAMP response element (CRE)
and a G+C-rich sequence, is the critical responsive element for Tax activation. Site-directed
mutagenesis analysis of the 35 bp region suggested that both the consensus CRE motif
and its upstream G+C-rich sequence were critical for Tax transactivation. Electrophoretic mobility
shift analysis (EMSA) using the 35 bp sequence as probe showed the formation of a specific
protein–DNA complex in HTLV-I-infected cell lines. EMSA with specific antibodies confirmed
that the CREB transcription factor was responsible for formation of this specific protein–DNA
complex. These results suggested that Tax directly transactivated ETR101 gene expression, mainly
through a CRE sequence via the CREB transcription pathway.
INTRODUCTION
Human T-cell leukaemia virus type I (HTLV-I) is a
retrovirus that is closely associated with various human
diseases, including adult T-cell leukaemia and HTLV-I-
associated myelopathy/tropical spastic paraparesis (Poiesz
et al., 1981; Yoshida et al., 1982; Gessain et al., 1985; Osame
et al., 1986). The pathogeneses of these diseases are still not
well understood but it has been shown that dysregulated
expression of cellular genes in HTLV-I-infected cells may
play a critical role in the development of HTLV-I-associated
diseases (Yoshida, 1996, 2001). Unlike acute leukaemia
viruses of animal origin, HTLV-I has no typical oncogene
derived from the cellular genome but it encodes a 40 kDa
nuclear phosphoprotein, Tax, which is encoded from the
39 end region of the HTLV-I genome. Tax can stimulate
HTLV-I gene expression through interactions with three
imperfect 21 bp repeats in the U3 region of the HTLV-I long
terminal repeat (LTR) (Fujisawa et al., 1985; Shimotohno
et al., 1986; Sodroski et al., 1984). To activate the HTLV-I
LTR, Tax requires at least two copies of the 21 bp repeat,
with each 21 bp repeat containing a central 8 bp off-
consensus cAMP response element (CRE) (Suzuki et al.,
1993; Zhao & Giam, 1992). Each off-consensus CRE is
flanked by a G+C-rich region critical for Tax transactiva-
tion of HTLV-I transcription. Previous studies suggested
that Tax activates the HTLV-I LTR by physical interaction
with the CREB/ATF protein family members, which bind
specifically to the 21 bp repeats (Zhao & Giam, 1992). In
addition to transactivating the HTLV-I LTR, Tax can also
activate many cellular genes that are normally controlled
by external stimuli, including genes for cytokines, cytokine
receptors, growth factors and an array of immediate–early
genes (IEGs), such as c-fos, c-myc, egr-1/krox-24, egr-2/krox-
20 and TR3/nur77 (Alexandre et al., 1991; Ballard et al.,
1988; Chen et al., 1997, 1998; Duyao et al., 1992; Fujii et al.,
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1988, 1991; Inoue et al., 1986; Nagata et al., 1989; Trejo et al.,
1997). Thus, HTLV-I Tax can functionally mimic extra-
cellular stimuli by interacting with cellular components
that are involved in the transduction of the activating signal
from the cell membrane to nuclear target genes.
IEGs are rapidly and transiently expressed during the early
stage of induction by growth factors or other stimuli, leading
to growth arrest or stimulation. Tax has been shown to
transactivate IEGs through various cellular transcription
factors, including CREB/ATF protein family members, NF-
kB, serum response element (SRE)-binding factor p67SRE,
activation protein 1 (AP-1) and Sp1 (Fujii et al., 1992; Hirai
et al., 1992; Leung & Nabel, 1988; Liu et al., 1999; Low et al.,
1994). Thus, the aberrant cell growth through the activa-
tion of IEGs by Tax could be an initial step in the deve-
lopment of HTLV-I-related diseases.
During the screening of Tax-regulated cellular genes by
DNA microarray analysis, the ETR101 (early TPA response)
gene was found to be strongly expressed in Tax-expressing
cells (unpublished data). ETR101 was cloned originally
from activated T-lymphocytes treated with cycloheximide,
a TPA-treated promyelocytic cell line HL-60 and serum-
stimulated BALB/c 3T3 fibroblasts (Charles et al., 1990;
Coleclough et al., 1990; Shimizu et al., 1991). ETR101 has
also been called pip92 and chx1. ETR101 is one of the IEGs
that is expressed immediate–early upon induction by TPA
in the human myeloid leukaemia cell line HL-60 (Shimizu
et al., 1991). ETR101 is rapidly and transiently induced by
stimulation with serum and growth factors in fibroblasts
(Charles et al., 1990). In addition to cell growth, ETR101 is
also induced during neuronal differentiation by treatment
with nerve growth factor or upon membrane depolariza-
tion in PC12 pheochromocytoma cells (Charles et al., 1990).
Based on the gene structure and deduced amino acid
composition, ETR101 contains multiple phosphorylation
sites, suggesting possible post-translational activation by
protein kinase C due to its inducibility by TPA. ETR101 also
contains nuclear localization signals and has been proven
to be selectively expressed in the nucleus as a fusion pro-
tein when tagged with green fluorescent protein, suggesting
that ETR101 might be a nuclear protein (Chung et al.,
2000). Thus, it has been believed that ETR101 is a putative
transcription factor that mediates the expression of other
cellular genes.
In present study, we report the transcription activation of
ETR101 by HTLV-I Tax and analyse in detail the regulatory
mechanism in transactivation.
METHODS
Materials. All oligonucleotides were synthesized by DNA Techno-
logy. pCMV, pCMV-Tax and Tax mutant plasmids, M7, M22 and
M47, were obtained from W. Greene (Smith & Greene, 1990). The
reporter plasmid pE1b-luc, which contains a basal E1b (adenovirus)
promoter sequence, was constructed in our laboratory and has been
described elsewhere (Liu et al., 1999).
Cell culture. The human T-cell leukaemia cell line Jurkat (clone
E6-1) and the acute lymphoblastic leukaemia cell line Molt-4 were
obtained from ATCC. HTLV-I-transformed T-cell lines C8166-45
and MT-2 were obtained through the NIH AIDS Research and
Reference Reagent Program (Harada et al., 1985; Salahuddin et al.,
1983). All these cells were grown in RPMI 1640 medium supple-
mented with 10% FCS at 37 uC under 5% CO2. The Tax-inducible
JPX-9 and control JPX/M cell lines were maintained under the same
conditions. Expression of biologically active Tax or a non-functional
Tax mutant was induced by the addition of CdCl2 to a 10 mM final
concentration (Nagata et al., 1989).
Plasmids. The 1430 bp (21393 to +37) fragment in the 59-
flanking region of the human ETR101 gene was obtained by PCR
using human MT-2 genomic DNA as template. The primers used
for PCR were 59-AGCTAAGCTTCGGACAACGGGCTCGCTCA-
AC-39 (reverse, +18 to +37) and 59-AGCTCTCGAGCACCCGGCT-
GGAATGCGAGTCA-39 (forward, 21393 to 21372). The amplified
PCR product was digested with XhoI/HindIII and cloned into pGL2-
Basic (Promega), which resulted in pGL2_ETR-1393. For the
construction of various length DNA fragments from the ETR101 gene
promoter, PCR was performed using pGL2_ETR-1393 as template.
PCR products were cloned into the XhoI/HindIII sites of pGL2-
Basic. The oligonucleotides containing potential Tax responsive
element (TRE) sequences (see Fig. 3B) in the ETR101 gene promoter
were synthesized, annealed and cloned into the XmaI/XhoI sites of
pE1b-luc. Likewise, the oligonucleotides with various mutations (see
Fig. 5) were cloned into pE1b-luc. pGL2_ETR-1393 was used as
template to generate the ETR101 gene promoter carrying specific
point mutations, created using the QuikChange Site-Directed
Mutagenesis kit (Stratagene). Nucleotide sequences of all constructs
were confirmed by DNA sequencing.
Cell transfection and assay of reporter gene activity.
Transfection was performed using the cationic lipid method, as
described previously (Liu et al., 1999). The pSV-b-galactosidase
plasmid (Promega) was included in each transfection experiment to
normalize transfection efficiency. Luciferase activity was assayed
using the Steady-Glo Luciferase Assay reagent (Promega) and
measured in a luminometer (Wallac 1420 Victor2, EG&G Wallac).
Luciferase activity in individual samples was normalized on b-
galactosidase activity measured using the b-Galactosidase Enzyme
Assay system (Promega).
Real-time quantitative PCR. Primers for the ETR101 gene were
designed with the Lasergene software package DNASTAT (forward,
59-CTTCGGGTGGGAGCGGGGACTGAT-39; reverse, 59-GGGCA-
CGCTGGAACCTGGGAACC-39). Cytoplasmic RNAs were collected
at different time-points after transfection in Jurkat cells and purified
using the RNeasy Midi kit (Qiagen). Real-time PCR was performed
as described previously (Fink et al., 2001). Advance Taq Plus DNA
polymerase (Clontech) and SYBR Green I Fluorophore (Molecular
Probes) were used in a two-temperature cycling, consisting of a
denaturation step of 95 uC for 15 s and an annealing/extension step
of 68 uC for 30 s. The predicted size and optimal concentration of
primers were checked prior to routine use. To normalize the input
load of cDNA among samples, 18S rRNA was quantified in a sepa-
rated real-time PCR analysis and used as an endogenous standard
(Fink et al., 2001). For the quantitative analysis of individual genes,
four independent cDNA samples were prepared from each culture
and each of the cDNA samples was tested in duplicate.
Northern and Western blot analysis. For Northern blot analysis,
cytoplasmic RNA was prepared from different cell lines using the
RNeasy Midi kit. RNA (5 mg) was separated in a 1% formaldehyde/
agarose gel and transferred to a PVDF-N membrane (Millipore)
using vacuum transfer. The probes for ETR101, tax and GAPDH
were prepared from IMAGE clone 187164 (UK HGMP Resource
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Centre), pCMV-Tax and pHcGAP, respectively, and labelled with
the Strip-EZ DNA Random-Primed StripAble DNA Synthesis and
Removal kit (Ambion). Hybridization was performed as described
previously (Chen et al., 1997). For Western blot analysis, 10 mg
protein was subjected to electrophoresis on a 12% denaturing poly-
acrylamide gel and transferred to a PVDF-P membrane (Millipore)
using a semi-dry blotting system (Owl Separation system). Anti-Tax
antibodies (Lt-4 and TAXY-8) were obtained from Y. Tanaka
(Tanaka et al., 1991). Protein detection was performed with the ECL
Western Blotting Detection system (Amersham Pharmacia Biotech).
Electrophoretic mobility shift analysis (EMSA). Nuclear
extracts of Jurkat, Molt-4, C8166-45 and MT-2 cells were prepared
according to an established protocol (Liu et al., 1999). Double-
stranded oligonucleotide ETR-p35 (sequence shown in Fig. 5A)
was end-labelled with [a-32P]dCTP (800 Ci per mmol) and DNA
polymerase Klenow fragment (Invitrogen) at room temperature
for 30 min. Then, 32P-labelled ETR-p35 was purified with the
MicroSpin G-25 column (Amersham Pharmacia Biotech). Binding
reactions were performed by incubating 4 mg nuclear extract with
2 mg poly(dI-dC) and 1 mg BSA in 14?5 ml binding buffer (12 mM
HEPES-KOH, pH 7?9, 60 mM NaCl, 1 mM MgCl2, 1 mM DTT,
12% glycerol and 0?2% Nonidet P-40) on ice for 30 min. Then,
approximately 26 000 c.p.m. 32P-ETR-p35 was added and incubated
at room temperature for 20 min. The binding reaction mixture was
resolved on a 5% non-denaturing polyacrylamide gel (40 : 1 acryl-
amide/bisacrylamide) at 4 uC for 2?5 h in 0?256 TBE and developed
on a Packard InstantImager (Packard Instrument). For competition
analysis, a 50-fold molar excess of cold probe was added to the
binding reaction mixture and incubated on ice for 30 min before
addition of 32P-ETR-p35. The probes containing the consensus
binding sites for AP-1, AP-2, AP-3, CREB, NF-kB, NF1/CRF, Sp-1
and Oct-1 were from Stratagene. For EMSA, nuclear extracts were
pre-incubated in the binding buffer on ice for 30 min with 1 mg
poly(dI-dC), 1 mg BSA and 1 pmol double-stranded ETR-p35-mu5.
Then, 26 000 c.p.m. 32P-ETR-p35 was added and incubated at room
temperature for 20 min prior to addition of 1 mg specific antibody.
Reaction mixtures were incubated at 37 uC for 30 min and subjected
to electrophoresis and detection. Antibodies for c-Jun (N), JunB
(N-17), JunD (329), c-Fos (4), ATF-1 (FI-1), ATF-2 (C-19), ATF-3
(C-19) and ATF-4 (C-20) were from Santa Cruz Biotechnology and
the antibody for CREB was from Upstate Biotechnology.
Sequence analysis. A multiple sequence alignment was performed
with the program CLUSTALX (Jeanmougin et al., 1998) and the
output format was processed further with the program GENEDOC.
Scanning of possible transcription-binding sites was performed by
searching against the TRANSFEC database (Wingender et al., 2000).
RESULTS
Expression of ETR101 in HTLV-I-infected and
Tax-expressing cells
Northern blot analysis was performed to analyse ETR101
expression in HTLV-I uninfected Molt-4 cells or HTLV-I-
transformed MT-2 and C8166-45 cells. Our results showed
that high levels of ETR101 expression were detected in both
MT-2 and C8166-45 cell lines, which constitutively express
Tax, but not in Molt-4 cells (Fig. 1A). The effect of Tax on
ETR101 expression was also examined in Tax-inducible
cell lines. JPX-9, a derivative of Jurkat cells, contains an
inducible Tax cDNA under the control of the metallothio-
nein promoter. JPX/M cells are counterparts of JPX-9 cells,
which contain a functionally inactive Tax point mutant (a
single arginine insertion at residue 62) (Nagata et al., 1989;
Neuveut et al., 1998). Expression of tax and its mutants
can be induced with 10 mM CdCl2. As shown in Fig. 1,
induction of tax and mutant tax expression by CdCl2 was
readily detected after 4 h of incubation in JPX-9 and
JPX/M cells. In parallel, expression of the ETR101 gene was
undetectable until 4 h of incubation and kept increasing at
the similar time lag as that of tax expression in JPX-9 cells,
but not in mutant tax expression JPX/M cells. This result
showed that Tax expression is responsible for the increase in
ETR101 expression observed in HTLV-I-transformed cells.
To further investigate the dependence of ETR101 expres-
sion upon Tax, Tax-expressing pCMV-Tax or the empty
vector pCMV were transiently transfected into Jurkat cells.
Cytoplasmic RNA was collected at different time-points
after transfection. Real-time PCR and Western blotting
were performed to detect the expressions of the ETR101
gene and tax after transfection (Fig. 1B). In cells trans-
fected with pCMV-Tax, real-time PCR data showed that tax
transcripts were readily detected within 3 h and reached a
peak at 6 h after transfection. Expression of tax was
detectable at 3 h and reached the highest level within
18 h. In accordance with this expression pattern, expres-
sion of ETR101 transcripts consistently increased for 12 h
to around 2?8-fold higher than that observed in cells
transfected with pCMV. This result indicated that the
expression of the ETR101 gene is directly associated with the
expression of tax in HTLV-I-transformed cells.
Structure of the ETR101 gene promoter and its
responsiveness to Tax transactivation
To analyse the regulatory mechanisms of ETR101 gene
expression, the genomic sequences of the 59-flanking region
of both human and mouse ETR101 were aligned with
CLUSTALX. As shown in Fig. 2, 1430 bp of 59 upstream
sequence of the human ETR101 gene showed 52% sequence
similarity with the mouse counterpart. Further sequences
upstream had little similarity (data not shown). Therefore,
it is highly plausible that the regulatory elements of ETR101
gene expression were situated in the 1430 bp region (the
transcription start site was numbered as+1). The 1430 bp
sequences were analysed with TRANSFEC to search for
potential binding site(s) for transcription regulation
(Wingender et al., 2000). Several potential TREs were
noted, including two Ets motifs (positions 21276/21271
and 21218/21213), two CArG-like motifs (positions
21232/21223 and 21180/21171), two NF-kB motifs
(positions 2212/2203 and 2120/2111) and one CRE
(position278/271). The 1430 bp (21393 to+37) ETR101
gene promoter sequence was amplified from MT-2 cells
and cloned into pGL2-Basic (pGL2_ETR-1393). ETR101
gene promoter activity was analysed by co-transfecting
pGL2_ETR-1393 with pCMV-Tax into Jurkat cells. An
8?3-fold increase in promoter activity upon Tax expression
was observed, indicating strong activation of the ETR101
gene promoter by Tax (Fig. 3A).
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Mapping of TRE in the ETR101 gene promoter
To identify the region necessary for the response to Tax
transactivation, we cloned various fragments of the
59-flanking region of the ETR101 gene upstream from
the transcription initiation site into luciferase reporter
vector pGL2-Basic. These constructs were transiently co-
transfected with pCMV-Tax or pCMV and their luciferase
activities were determined. As shown in Fig. 3(A), the
luciferase activity of pGL2_ETR-1393 increased by around
8?3-fold compared with that of cells co-transfected with
pCMV. After deletion of both Ets and CArG-like motifs,
progressive deletions of pGL2_ETR-679 and pGL2_ETR-
311 show no significant decrease in luciferase activities and
ratio of induction (8?3-fold and 12?3-fold, respectively).
Further deletion of two possible NF-kB-binding motifs
(pGL2_ETR-110) resulted in around 50% reduction in
promoter activity, but the induction ratio kept to 11-fold.
Further deletion of an additional 42 bp (pGL2_ETR-68)
totally abolished responsiveness to Tax transactivation.
These results indicated that the essential sequence motifs
in response to Tax transactivation on the ETR101 gene
promoter are situated between positions 2310 and 268.
The region at 2110/268 may contribute mainly to Tax
transactivation.
To define further the region responsive to Tax transactiva-
tion in the ETR101 promoter, the representative fragments
in the region 2310/268 were cloned into the pE1b-luc
reporter plasmid and placed directly in front of the basal
adenovirus E1b TATA-box sequence (Liu et al., 1999). As
shown in Fig. 3(B), the 2310/2175 region (as represented
by 2310/2265, 2280/2235, 2240/2195 and 2220/2175
fragments) was not responsive to Tax. The 2140/2100
region of the ETR101 gene promoter, which includes the
second potential NF-kB-binding motif, can be activated
4?2-fold by Tax. The 298/264 region resulted in an
11-fold increase in its activity in response to Tax, which is
equivalent to pGL2_ETR-110 in response to Tax (Fig. 3B).
This result indicated that the region at positions2140/264,
Fig. 1. Transactivation of ETR101 expression in HTLV-I-transformed cell lines and Tax-expressing cells. (A) Northern blotting
analysis of ETR101-, tax-, and GAPDH-specific transcription expression in HTLV-I-transformed cell lines and Tax-inducible
expression cell lines. Total RNA (5 mg) from HTLV-I uninfected Molt-4- and HTLV-I-transformed C8166-45 and MT-2 cells
was separated in a 1 % formaldehyde/agarose gel. The JPX-9 and JPX/M cells stably transfected with tax and mutant tax
genes under the control of inducible promoters were analysed after tax induction with 10 mM CdCl2 at the intervals indicated.
Expression of the GAPDH gene was analysed for standardization purposes. (B) Real-time PCR and Western blot (WB)
analysis for the expression of ETR101 and Tax in Jurkat cells transiently transfected with control pCMV and Tax-expressing
pCMV-Tax plasmids. The ratio of ETR101 and Tax expression in cells separately transfected with pCMV-Tax to pCMV were
calculated at each time-point as fold induction. Cell lysate (10 mg) from pCMV-Tax-transfected Jurkat cells at each time point
was analysed for Tax expression by Western blotting using Tax-specific Lt-4 antibody.
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Fig. 2. Sequence alignment of human and mouse ETR101 gene promoters. Numbers referred to are relative to the transcription start site at +1.
Sequence alignment was performed using CLUSTALX and the output format was processed further with GENEDOC.
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harbouring potential NF-kB and CRE motifs, is involved
in the Tax activation of the ETR101 gene promoter.
Point mutation studies were performed to further confirm
the critical TREs in the ETR101 promoter. Mutants of each
potential TRE on the ETR101 promoter were generated
and analysed in transient transfection with pCMV-Tax.
Mutations of each CArG-like element and the first putative
NF-kB-binding motif did not affect Tax activation of the
ETR101 gene promoter. These results are line with our
deletion analysis. Mutation of the second putative NF-kB-
binding motif resulted in a 15% reduction in the ratio of
Tax activation, from 8?3- to 6?2-fold. Mutation of the
potential CRE motif reduced the ratio of Tax activation
from 8?3- to 4?3-fold (48% reduction). Double mutations
of these two sites further lowered the induction ratio to
3?5-fold (59% reduction) (Fig. 3C). These data suggested
that the CRE and one of the putative NF-kB-binding
elements may be involved in Tax activation in the ETR101
promoter and that CRE is more prominent in response to
Tax transactivation.
Tax transactivation of ETR101 promoter activity
is dependent mainly on the CREB pathway
Contribution of CRE and NF-kB elements in Tax-activated
ETR101 expression was characterized further using Tax
mutants in transfection analyses. pGL2_ETR-1393 was
co-transfected with wild-type Tax and Tax mutant plasmids
M7, M22 and M47. The mutation within a zinc finger
domain of Tax (M7), which abolishes transactivation of
both CREB/ATF and NF-kB pathways, totally abolished
the Tax effect on the ETR101 promoter. Tax mutant M22
(T130S and L131A), which activates the CREB-dependent
pathway but not the NF-kB-dependent pathway, activated
pGL2_ETR-1393 reporter activity to approximately 82% of
wild-type. On the other hand, the M47 mutant, which is
defective in the CREB pathway but is fully active in the
NF-kB pathway, showed only 18% of activity compared
with wild-type Tax when co-transfected with the ETR101
promoter (Fig. 4). These results strongly suggested that Tax
transactivation of the ETR101 promoter is predominantly
dependent on the CREB pathway.
Site-directed mutagenesis of the cis-acting
elements of the proximal (”98/”64) TRE in a
heterologous reporter
Sequence analysis of this 35 bp ETR101 promoter showed
that it contains a consensus CRE sequence (TGACGTCA),
which is conserved between human and mouse promoter
sequences (Fig. 2). An 8 bp G+C-rich sequence in the 59
end of this region was also found. This 35 bp TRE was
cloned into the pE1b-luc plasmid and a series of muta-
tions were introduced to replace the consensus sequence.
Transfection results showed that m5 and m6 both disrupted
the CREmotif, rendering the promoter unresponsive to Tax
(Fig. 5A). Mutations of the 59 end G+C-rich sequence (m1
and m2) showed significantly different effects. Mutation of
GGCRAAA (m1) essentially abolished Tax responsiveness
but mutation of GGGRAAA (m2) reduced activity to
Fig. 3. Mapping of the TRE sequence in the ETR101 promoter region. Diagrams of different deletion constructs are shown
(A). Locations of possible functional elements are labelled at the corresponding positions and are indicated on top of the
sequence. The luciferase reporter vectors containing various lengths of the 59 end region of the ETR101 gene were
co-transfected together with pCMV-Tax (black bars) or the control pCMV (white bars) plasmids in Jurkat cells. (B) Analysis
of transcription activation of putative TRE sequences on the ETR101 promoter in a heterologous minimal promoter. The
different double-stranded oligonucleotides corresponding to positions ”310 to ”64 upstream of the transcription initiation
site of the ETR101 promoter sequence were constructed into the immediate upstream region of the minimal adenovirus
E1b promoter at the XmaI/XhoI sites of pE1b-luc. All reporter vectors were co-transfected with pCMV-Tax (black bars) or
the control pCMV (white bars) plasmids in Jurkat cells. (C) Mutational analysis of each putative TRE on Tax transactivation of
ETR101 promoter activity. Mutated sites are shown (X); constructs were named according to the positions of mutations.
Luciferase activities were quantified and normalized by b-galactosidase activity. pGL2_ETR-1393 with pCMV-Tax was given
a value of 100 % and the activities of the other transfection were adjusted relative to this activity. Bars represent the
means±SE of at least three replicates.
A
B
Fig. 4. Differential activation of pGL2_ETR-1393 reporter activity
by Tax and its mutants. (A) Jurkat cells were transfected with
pGL2_ETR-1393 and expression plasmids for wild-type Tax
(WT) and Tax mutants M7, M22 and M47. The percentage
of promoter activity was calculated relative to wild-type Tax.
(B) Expression of the wild-type and mutant Tax proteins in the
transfected cells were confirmed by Western blotting with Lt-4
and TAXY-8 anti-Tax antibodies.
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around 47%. Other mutants showed that the remaining
sequence was dispensable for Tax transactivation. These
results indicated that CRE and its 59 G+C-rich sequences
were essential for Tax transactivation of the ETR101
promoter. When compared with three HTLV-I LTR
21 bp TREs, the GGC sequence was also situated upstream
of off-consensus CRE (Fig. 5B). Mutation of this GGC
sequence in the 21 bp TRE abolished its Tax responsiveness
(Fujisawa et al., 1985). The sequence similarity between the
35 bp ETR101 TRE and HTLV-I LTR 21 bp TRE was not
observed in the vicinity of the CRE of human chorionic
gonadotropin (hCG), which is highly responsive to cAMP
stimulation but not to Tax transactivation (Fig. 5B).
EMSA analysis of a specific DNA–protein
complex in the ETR101 (”98/”64) region
To define the transcription factors specifically bound to
the 298/264 region of the ETR101 promoter, EMSAs
were performed with a 32P-labelled 35 bp sequence (32P-
ETR-p35) as the probe (sequence shown in Fig. 5). The
results showed that binding of nuclear extracts from Tax-
expressing cell lines C8166-45 and MT-2 with the probe
resulted in two binding complexes, the slow migrating
complex I (Com I) and the faster migrating complex II
(Com II) (Fig. 6A). In contrast, only Com I was detected
with nuclear extracts from Jurkat and Molt-4 cells. These
results suggested that the faster mobility Com II contains
the specific nuclear protein(s) to the ETR101 promoter
upon Tax expression and the slower mobility Com I
represents a constitutive binding activity irrespective of
induction by Tax. To verify the specific DNA-binding
motifs involved in the formation of Com I and Com II, a
competition analysis was performed with seven mutated
ETR-p35 probes (m1 to m7), used as cold probes. The
results revealed that Com II was efficiently competed out by
the cold probes m1–m4 and m7 but not by the cold probes
generated by m5 and m6, in which CRE (TGACGTCA) was
disrupted (Fig. 6B). These results demonstrated that the
CRE sequence is involved in the formation of Com II.
Moreover, Com I was not competed by cold probes m2 and
m3, indicating that the sequence covering both m2 and
m3 mutations is responsible for the formation of Com I.
The 59 G+C-rich sequence from the human ETR101 gene
(GGGCGGGG) is identical to the consensus Sp1-binding
motif. But the homologous region in the mouse ETR101
promoter showed a single base variation (GGGCGTGG),
which disrupts the consensus Sp1 site. The mutation in
m1 also disrupted this consensus Sp1 motif, but m1 could
compete Com I. These results suggested that the 59 G+C-
rich sequence did not represent a Sp1 motif and the 59
(GGGC) and 39 (GGGG) ends of this G+C-rich sequence
were functionally separated. To analyse these complexes
further, the 22–24 bp cold oligonucleotide probes with
consensus DNA-binding motifs (Sp1, NF1/CTF3, AP-1,
AP-2, Ap-3, NF-kB, CRE and Oct-1) were used for
competition analysis. As shown in Fig. 6(C), Com II was
competed away by the CRE or AP-1 probes (Fig. 6C), but
Sp1 could compete neither Com I nor Com II. These results
indicated that the transcription factor(s) in Com II might
belong to CREB/ATF or AP-1 families. But the proteins in
Com I were not related to Sp1 transcription factors.
To determine the members of the CREB/ATF and AP-1
transcription factor families that were involved in the
formation of inducible Com II, supershift assays with
antibodies against different members of the CREB/ATF
and AP-1 transcription factors were performed. Only in
the presence of anti-CREB antibody did Com II show
supershifted mobility (Fig. 6D), indicating that CREB is a
component in Com II. Collectively, these results indicated
that transcription factor CREB binding with CRE in the
ETR101 promoter contributes to Tax-regulated ETR101
expression.
DISCUSSION
In this report, we have investigated the expression of ETR101
in HTLV-I-transformed cells and its regulation by Tax. Our
work showed that ETR101 was constitutively expressed in
HTLV-I-transformed cells. The steady state accumulation
of ETR101 mRNA was induced in the Jurkat clone, JPX-9
upon Tax expression and in Jurkat cells transiently trans-
fected with Tax-expressing plasmid. These results suggested
that Tax was directly responsible for the constitutive expres-
sion of the endogenous ETR101 gene in cells transformed
by HTLV-I.
It has been reported previously that transcriptional activa-
tion of ETR101 by serum growth factors in the NIH 3T3 cell
line requires the SRE, which contains both the Ets and
Fig. 5. Site-directed mutagenesis of the 35 bp ETR101 pro-
moter region in response to Tax transactivation. (A) Illustration
of the 35 bp sequence of the ETR101 promoter (ETR-p35)
and its mutants. Mutations are indicated in bold, lowercase
letters. Wild-type and mutant ETR101 promoter reporter
vectors were co-transfected with the pCMV-Tax and control
pCMV plasmids in Jurkat cells. The activity of wild-type
ETR101 35 bp TRE was arbitrarily given the value of 1. The
activities of the mutants (m1–m7) were calculated and listed
accordingly. (B) Sequence comparison of the ETR101 35 bp
TRE with the three 21 bp HTLV-I LTR TREs and hCG CRE.
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CArG-like cis-acting elements, to form an Elk1–SRF–DNA
ternary complex (Latinkic & Lau, 1994; Latinkic et al., 1996).
The consensus sequence CC(A/T)6GG, termed the CArG
box, is the core sequence in the SRE that is present in the
promoters of many IEGs (Johansen & Prywes, 1995). The
CArG box also serves as the TRE for transactivation of
c-fos, egr-1 and egr-2 by Tax (Fujii et al., 1992). Deletion of
the SRE from the ETR101 promoter resulted in no signi-
ficant decrease in promoter activity in Tax transactivation.
In our report, specific mutations were also introduced to
disrupt both CArG-like elements. Mutations of these two
CArG-like elements in the ETR101 promoter have no effect
on Tax transactivation. The results indicated that the SREs
in the ETR101 gene promoter were not responsible for Tax
transactivation.
NF-kB defines a family of dimeric transcription factors
composed of a combination of NF-kB/Rel family members
that are able to mediate Tax transactivation of several
cellular genes, including c-myc and the IL-2 receptor
(Duyao et al., 1992; Leung & Nabel, 1988). Deletion of
two putative NF-kB-binding sites (2120/2110 and 2214/
2200) from the 347 bp fragment (pGL2_ETR-110) resulted
in a further 50% reduction in promoter activity, suggesting
Fig. 6. Gel shift analysis of ETR-p35-binding activity. (A) 32P-ETR-p35 (”98/”64 of the ETR101 promoter) was incubated
with 4 mg nuclear extract from HTLV-I-negative Jurkat and Molt-4 cells and from HTLV-I-transformed C8166-45 and MT-2
cells. Arrows indicate the DNA–protein binding complexes. Presence of Tax in nuclear extracts of C8166-45 and MT-2 was
detected with the Tax-specific antibody Lt-4. (B) Competition analysis with different ETR-p35 mutant probes. The 50-fold
molar excess of cold ETR-p35 mutant probes m1–m7 were pre-incubated with 4 mg nuclear extract on ice for 30 min before
addition of labelled ETR-p35 probe. (C) Competition analysis with 22–24 bp consensus transcription factor-binding probes.
The 50-fold molar excess of cold AP-1, AP-2, AP-3, CREB, NF-kB, NF1/CRF, Sp-1 and Oct-1 binding probes were
incubated with 4 mg MT-2 nuclear extracts on ice for 30 min before addition of labelled ETR-p35 probe. (D) Supershift
analysis. MT-2 nuclear extracts (4 mg) was incubated with 1 mg (1–2 ml) of anti-c-Jun, JunB, JunD, CREB, c-Fos, ATF-1, ATF-
2, ATF-3 and ATF-4 antibodies, respectively. As a control, 2 ml PBS was incubated in parallel (lane 1). The supershifted band
is indicated as Ss.
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that the NF-kB pathway may contribute to the basal
transcription activity of ETR101. But this deletion did not
change the fold induction of ETR101 promoter activity
by Tax. We performed point mutation analysis to disrupt
both putative NF-kB sites separately. Mutations of two
putative NF-kB elements has no effect on basal ETR101
promoter activity in Jurkat cells. It seems that the regulatory
elements other than these two putative NF-kB elements in
the 2310/2110 region may contribute to basal ETR101
promoter activity. We further analysed the effects of these
two mutations on Tax responsiveness. Only the second
NF-kB element (2120/2110) has moderate effect on Tax
transactivation. Although this NF-kB element can respond
to Tax transactivation when cloned into a heterologous
E1b basal promoter, analysis using a Tax mutant depleted
in NF-kB transduction pathway (M22) has little effect on
Tax transactivation of the ETR101 promoter. This indicated
that the NF-kB transduction pathway had very weak or no
direct effect on Tax-regulated ETR101 expression.
Deletion of the 42 bp sequence containing the consensus
CRE (TGACGTCA) from the ETR101 promoter com-
pletely abolished its Tax responsiveness, implying the
critical element responsive to Tax located to this region.
Mutating the consensus CRE sequence results in 60%
reduction in Tax transactivation of the promoter activity.
It strongly indicates that the CRE motif was the critical
responsive element to Tax in the ETR101 promoter. This
result is further solidified by additional studies with Tax
mutant M47, which is defective in the CREB signal
transduction pathway. In addition to the consensus CRE
sequence, this region contains a 59 G+C-rich sequence
(GGGCGGGG), which is identical to a consensus Sp1-
binding motif. But the same region in the mouse ETR101
promoter has a single base variation (GGGCGTGG) that
disrupts the consensus Sp1 site. This sequence variation
indicated that this G+C-rich sequence might not function
as an Sp1-binding motif in the ETR101 promoter. A series
of site-directed mutagenesis studies of this 35 bp TRE
sequence showed that disruption of CRE (m5 and m6)
abolished Tax transactivation activity, indicating the res-
ponsiveness of this CRE to Tax transactivation. To verify
the specific transcription factors mediating the transactiva-
tion of ETR101 by Tax, EMSA was performed with specific
antibodies from both AP-1 and CREB/ATP families of
proteins. As expected, only anti-CREB antibody super-
shifted the protein(s) bound to the 35 bp ETR101 TRE.
These results clearly demonstrated that Tax activates the
ETR101 gene promoter via interaction with CREB.
The ETR101 TRE bears several sequence similarities to
three 21 bp HTLV-I LTR TREs. Both structures contain a
CRE with 59 and 39G+C-rich sequences in its close vicinity.
59 GGC sequences were critical for both the ETR101 35 bp
and the LTR 21 bp TREs, while the 39 G+C-rich sequences
are dispensable to Tax transactivation. It is well recognized
that the consensus CRE (TGACGTCA) without specific
upstream sequence is not sufficient for Tax responsiveness
(Fujisawa et al., 1989). The flanking G+C-rich sequences
are critical for the entry of Tax into the complex containing
CREB and for the enhanced binding of CREB to the CRE
core sequence (Brauweiler et al., 1995; Paca-Uccaralertkun
et al., 1994; Yin & Gaynor, 1996). Our EMSA analysis
showed that this G+C-rich sequence was functionally
separated. The 39 end of this G+C-rich sequence (GGGG)
was engaged in the formation of a specific DNA–protein
complex (Com I), although formation of this complex did
not depend on Tax expression. It is not known based on
our current data which protein is involved in formation
of this complex, but Sp1 is not a component, as revealed by
competition analysis. From our data, formation of Com I
had no effect on Tax-associated formation of Com II via
the downstream CRE. The 59 end of this G+C-rich region
(GGC) was not involved in the formation of Com I, but
mutation of the GGC sequence (m1) also abolished its
response to Tax activation of ETR101. Comparing the
flanking region of CRE elements between ETR101 and
hCG, this GGC sequence is not present in immediate
upstream regions of hCG CRE. This may provide an
explanation as to why hCG CRE is not Tax responsive.
We report the finding of transcription activation of the
ETR101 gene by Tax and show a detailed analysis of the
TREs in its promoter region. Although the significance of
ETR101 expression in the regulation of cell-cycle progress
has not been well investigated, its weak sequence similarity
with the c-jun oncogene and its expression during G0/G1
transition hint to the possible functions in the control of
cellular activation and transformation. It is interesting to
note that the ETR101 gene is localized in the same region
on chromosome 19 as the human junB and junD proto-
oncogenes (Scott et al., 1994). Translocations involving this
region of chromosome 19 have been observed frequently
in some cases of acute non-lymphoblastic leukaemia and
acute lymphoblastic leukaemia (Mitelman et al., 1990). As
documented previously, Tax can induce multiple mes-
enchymal tumours and leukaemia in transgenic mice
(Grossman et al., 1995; Nerenberg et al., 1987) and it can
alter the growth properties of rodent fibroblast cells and
human T-cells (Nerenberg et al., 1987; Schmitt et al., 1998).
Therefore, further analysis of ETR101 function may provide
more information, necessary for better understanding of
Tax-induced cellular transformation.
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